Unknown

Dataset Information

0

Frequent silencing of the candidate tumor suppressor TRIM58 by promoter methylation in early-stage lung adenocarcinoma.


ABSTRACT: In this study, we aimed to identify novel drivers that would be epigenetically altered through aberrant methylation in early-stage lung adenocarcinoma (LADC), regardless of the presence or absence of tobacco smoking-induced epigenetic field defects. Through genome-wide screening for aberrantly methylated CpG islands (CGIs) in 12 clinically uniform, stage-I LADC cases affecting six non-smokers and six smokers, we identified candidate tumor-suppressor genes (TSGs) inactivated by hypermethylation. Through systematic expression analyses of those candidates in panels of additional tumor samples and cell lines treated or not treated with 5-aza-deoxycitidine followed by validation analyses of cancer-specific silencing by CGI hypermethylation using a public database, we identified TRIM58 as the most prominent candidate for TSG. TRIM58 was robustly silenced by hypermethylation even in early-stage primary LADC, and the restoration of TRIM58 expression in LADC cell lines inhibited cell growth in vitro and in vivo in anchorage-dependent and -independent manners. Our findings suggest that aberrant inactivation of TRIM58 consequent to CGI hypermethylation might stimulate the early carcinogenesis of LADC regardless of smoking status; furthermore, TRIM58 methylation might be a possible early diagnostic and epigenetic therapeutic target in LADC.

SUBMITTER: Kajiura K 

PROVIDER: S-EPMC5356850 | biostudies-literature | 2017 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Frequent silencing of the candidate tumor suppressor TRIM58 by promoter methylation in early-stage lung adenocarcinoma.

Kajiura Koichiro K   Masuda Kiyoshi K   Naruto Takuya T   Kohmoto Tomohiro T   Watabnabe Miki M   Tsuboi Mitsuhiro M   Takizawa Hiromitsu H   Kondo Kazuya K   Tangoku Akira A   Imoto Issei I  

Oncotarget 20170101 2


In this study, we aimed to identify novel drivers that would be epigenetically altered through aberrant methylation in early-stage lung adenocarcinoma (LADC), regardless of the presence or absence of tobacco smoking-induced epigenetic field defects. Through genome-wide screening for aberrantly methylated CpG islands (CGIs) in 12 clinically uniform, stage-I LADC cases affecting six non-smokers and six smokers, we identified candidate tumor-suppressor genes (TSGs) inactivated by hypermethylation.  ...[more]

Similar Datasets

2017-06-10 | GSE85301 | GEO
| S-ECPF-GEOD-32492 | biostudies-other
| S-EPMC5005773 | biostudies-literature
| S-EPMC2966466 | biostudies-literature
| S-EPMC4504988 | biostudies-literature
| S-EPMC7762488 | biostudies-literature
| S-EPMC7793369 | biostudies-literature
2011-10-02 | E-GEOD-32492 | biostudies-arrayexpress
| S-EPMC6399005 | biostudies-literature
2011-10-03 | GSE32492 | GEO